EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS091-07904 
Organism
Homo sapiens 
Tissue/cell
HepG2 
Coordinate
chr11:65168340-65171400 
TF binding sites/motifs
Number: 12             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
IRF9MA0653.1chr11:65169502-65169517TGTTTCGGTGTCGTT-6.11
ONECUT1MA0679.1chr11:65169963-65169977TATATTGATTTTTG-6.26
ONECUT2MA0756.1chr11:65169963-65169977TATATTGATTTTTG-6.36
ONECUT3MA0757.1chr11:65169963-65169977TATATTGATTTTTG-6.6
ZNF263MA0528.1chr11:65168843-65168864CTTCCCTCCCCAGCCTCCCTC-6.11
ZNF263MA0528.1chr11:65168830-65168851CCTCCCTCCCCTGCTTCCCTC-6.16
ZNF263MA0528.1chr11:65168858-65168879TCCCTCCCCTGCCCCTCCCTC-6.52
ZNF263MA0528.1chr11:65168778-65168799CCTCCCTCCCCAGCCTCCCTC-6.54
ZNF263MA0528.1chr11:65168791-65168812CCTCCCTCCCCAGCCTCCCTC-6.54
ZNF263MA0528.1chr11:65168804-65168825CCTCCCTCCCCTGCCTCCCTC-7.19
ZNF263MA0528.1chr11:65168817-65168838CCTCCCTCCCCTGCCTCCCTC-7.19
ZfxMA0146.2chr11:65170897-65170911CCCGCCTCGGCCTC+6.01
Number of super-enhancer constituents: 20             
IDCoordinateTissue/cell
SE_09254chr11:65170631-65172048CD14
SE_10174chr11:65170629-65172617CD19_Primary
SE_10943chr11:65168731-65173246CD20
SE_12863chr11:65170913-65171657CD34_Primary_RO01480
SE_14055chr11:65168909-65169507CD34_Primary_RO01549
SE_14055chr11:65170621-65172649CD34_Primary_RO01549
SE_14385chr11:65170918-65172312CD4_Memory_Primary_7pool
SE_19987chr11:65170621-65172169CD56
SE_23730chr11:65167786-65169333Colon_Crypt_2
SE_29609chr11:65170859-65171961Fetal_Muscle
SE_30977chr11:65170828-65172094Fetal_Thymus
SE_32521chr11:65170521-65172294GM12878
SE_39868chr11:65170818-65171493K562
SE_55118chr11:65170903-65171686Thymus
SE_58461chr11:65170809-65225246Ly1
SE_58925chr11:65170783-65198465Ly3
SE_59648chr11:65169738-65223378Ly4
SE_60421chr11:65157742-65225276DHL6
SE_61166chr11:65170820-65199975HBL1
SE_62214chr11:65170357-65224596Tonsil
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr116516881765169551
chr116517077665171400
chr116516897065169000
Number: 2             
IDChromosomeStartEnd
GH11I065400chr116516768165170116
GH11I065402chr116517035565172649
Enhancer Sequence
AGCGCGGGTG GTGCCTGCAC ACGGGTGGGG AGGCTGGGCC CAGGTGCCCT GGGTCCCAGA 60
CAATTAGAGG CACCAGGCTG GCGGGCAAGG AGGTGAGAAG CTGCCTTGGG CCTGAGGATG 120
AAAGCGGCCT GGGCACAAGG GGTGCCTTGA GTCCTGCTGA CCCAGAGCTG CCCTGGGAGG 180
TCAGGAGGCC TGGTCTGCAG ACTCCACGCC GGTGGTGGTG GCAGCTGTGG GGTTCGGGCA 240
GCTGTTTGTT GAGGGCTTGC TGAGTGCTTT GAGACCAGCC TGCACCCTCC CCTCCTGTCC 300
CCAAGACCAG TGCTGTTGTG ACCCTATTCA CAGTCACCTG CGGTGGGCGT GGAAACGTTG 360
GGCCTCTCCA AGCCTGTGTT TGATTTTCCC CTTCATTCGT CGTGTTTTAC TCAGCACCGA 420
GCACCTCTTC TACCCCAGCC TCCCTCCCCA GCCTCCCTCC CCAGCCTCCC TCCCCTGCCT 480
CCCTCCCCTG CCTCCCTCCC CTGCTTCCCT CCCCAGCCTC CCTCCCCTGC CCCTCCCTCT 540
CCCACTTGGG TCACATCAGA CGCCCCTCCC TCCCACAGGG CCCTTTCAGG ACTGTTCCCA 600
CCCCTTCCTC CTTTCATCTC GGGTCTCTCT GGATCCTTCA TTCCACACCT CTCCGGCTTC 660
CTTTTGGTGC CCTTCACCCC TCCCTTGGCA GCCAGACCCC ACCCCTGCGC CTCCCATGCT 720
GGGGGCTGCT TCTAGCCCCA TCGGCCTCTG CTTTGCCACA GGAGGGCCCC CTCCCCCTTC 780
TCAGCTTAAC TACATGCTCC TGGAAGCTTC TTTCCGCCCC CACCAGCCAC CTCCTCCCCC 840
AGCTTCCCCT GCTGCTCCCC ATTTTCCTGG CCCCCCTCGA GGGCACTCCT CTCCCTGCCT 900
CATGGCTTTG AACTCCAAGA TATTCTCACC TTTATGTTCA AAGTTCACAA TTTTCTTTTT 960
TTTTTTTTTT TTTTGAGACG GAGACTGGTT TATGCTTTTT GTTTCCTAAG AAATTTTGCC 1020
TAACCCAAGA CCACAAAGAT TTTCTCATGT TTTCTTGTAG AAGTTGTATA AATTTAAGCC 1080
TCCCAGCCAT CCCAAAGTCA ATATTTTACA TCAGGTGTGA TATACAGGTC AATGTTCATG 1140
TTCGTGTTTA CAGATTCTCA ATTGTTTCGG TGTCGTTTGT TGAAAAGACA TTGAATTGGC 1200
CGGGCATGGT GGATCACGCC TGTAATCCCA GCACTTTGGG AAGCCAAGGT GGGCGGATCT 1260
CTTTAGGCTC AGAGCTCAAG ACCAGCCTGG CCAACAAGGT GAAACCCCCA TCTCTACTAA 1320
AAATACAAAA AATTGGCCGG GTGTGGTGGC ACACGCCCGT AATCCCAGCT ACTACTTGGG 1380
AGACTGAGGC ACGAGAATCA CTTGAACTGG GGAGGCAGAG ATTGTGGTAA GCCGAGATGG 1440
TGCCACTGCA CTCCAGCCTA GGCAACAGAG TGAGACTCTG TCTCAAAAAA AAAAAAAAGA 1500
AAGACATTGA ATTGCCCTGA CATCTTTGTT GAAAATCAAT TGGCTGTACA TGTGTGGGTC 1560
TGTTTCTGGA TTCCCTCTTC TAAACCACTG ATATATGTGT GTCTTTCACT GATAATCACA 1620
CTATATATTG ATTTTTGAAC CTTTATAATA AGTCTTGAAA TCAGGTAGTC TGATAACCAG 1680
AACTTTGTTC TTTTTAAAAT GGTTTCCATA GAAGTTTTAG AATCAGCTTG TTGATTTGTA 1740
GCATGCTCCG CTATCCACCC CCCAAAAAAA GGCTACCTAG GATTTTTATT GAGATCGCAT 1800
TGATTACTTC GGAGGTCATT GACCTCTTAA GTCTTCCAGT CCATTTATTT CTGTATCTCC 1860
ATTTATTTGT CTCTGATTTC TTTCATTAAC ATTTTATAGT TTTCAGCATA CAAAACTTCT 1920
GCATCTTTTG TTAGATTTAT CCATTTCTTT TTTTTTTTCT TTTGGTGCTA CTGTAAATGG 1980
CACTGTTTTT AATTTCAATT TCCAATTGAT CATTTCCTTA TATAGAAATA TAATTGTTTT 2040
TGTTTTTTTT GAAACACTCT TGCTCTGTCA CCGAGGCTGG GGTGCAGTGG CGCAATCATA 2100
GCTCACTGCA TCCTTGACCT CTGGGCTCAA GCTATCATCC CAAGCCACAG GTGTGCACCA 2160
CCATGCCAGG CTAACTTTAT TTTATATTTG TAGAGACAAG GTCTCACTAT GTTGCCCAGG 2220
CTAATCTTGA ACTCCTGGGC TCAAGTGATT CTCCCACCTT GGCCTCCCAA AGTGCTGGGA 2280
TTACAGGCAT GAGCCCCTGT GTCTGCCTTT TTTCTTTTTT TCTTTTTTTT TGAGATGGAG 2340
TCTCACTCTG TCGCCCAGGC TGGAGTGCAA TGGCGCGATT TCAGCTCACT GCAACCTCCG 2400
CCTCCTAGGT TCAAGCGATT CTCTCACCTC AGCCTCCTGA GTAGCTGGGA TTACAGGAGC 2460
CTGCCATCAC ACCCAGCTAA TTTTTGTATT TTTAGTAGAG ATGGGTTTTC ACCATGTTGG 2520
CCAGGCTGGT CTCAAACTCC TGACCTCAGG TGATCCACCC GCCTCGGCCT CCCAAAGTGT 2580
TGGGATTACA GGCGTGAGCC ACGGCACCTG GCCTGGCCTG GGACTTTCTA TGTGGACAGT 2640
CGTGTGGTCT GTGAGTTGGG ACAGCTGGGT CTCACTTTCC AATCTGTGTG CCTCTTGCTT 2700
GCCTTGCCTG ACAGTGCTTC TGACCCCCAG TGTAGGATGG ATAGGTGTGC GCAGGCGTCC 2760
CTGACGCACC TGGCCTGAGA GAGAACATTG TCTTTCACTG AATAAGTGGG ATTTTGCTGT 2820
GGGTTCTTCA GAGATGCGCT TCATCAGGTT GAGGAAGTTC CTTTCTGACG CTGGCTTGCT 2880
GAGTTTTATC TTGGACAGAT GTTCAGCAGA GCTTCCTCTT TTGGCTGCAT TTGAACGGCA 2940
GGCTTCCTGA GCCTCAGAGG CATGTTGCTG TGCAGGAGTT TTTGTTCTAG GAAACTTAGT 3000
AGGCTTCCCT GTTATGGTTG CACTCAGGAC TCTGTCCCCA CCGGCTGCCG TCCCCTCGCC 3060